Designing Dendrimers For Drug Delivery And Imaging Pharmacokinetic Considerations

We have collected information about Designing Dendrimers For Drug Delivery And Imaging Pharmacokinetic Considerations for you. Follow the links to find out details on Designing Dendrimers For Drug Delivery And Imaging Pharmacokinetic Considerations.


Designing dendrimers for drug delivery and imaging ...

    https://www.ncbi.nlm.nih.gov/pubmed/21181549
    Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations. Wijagkanalan W(1), Kawakami S, Hashida M. Author information: (1)Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8501, Japan. [email protected]: Wassana Wijagkanalan, Wassana Wijagkanalan, Shigeru Kawakami, Mitsuru Hashida

Designing Dendrimers for Drug Delivery and Imaging ...

    https://link.springer.com/article/10.1007/s11095-010-0339-8
    Dec 23, 2010 · A better understanding of the basic aspects of dendritic systems and their pharmacokinetics will help to develop a rationale for the design of dendrimers for the controlled delivery of drugs and imaging reagents for therapeutic or diagnostic purposes.Author: Wassana Wijagkanalan, Wassana Wijagkanalan, Shigeru Kawakami, Mitsuru Hashida

Designing Dendrimers for Drug Delivery and Imaging ...

    https://www.researchgate.net/publication/49705440_Designing_Dendrimers_for_Drug_Delivery_and_Imaging_Pharmacokinetic_Considerations
    Request PDF Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations Dendrimers have well-organized high branches with a layered architecture providing a series of ...

(PDF) Dendrimers in anticancer drug delivery

    https://www.researchgate.net/publication/320353147_Dendrimers_in_anticancer_drug_delivery
    Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations. ... for the design of dendrimers for the controlled delivery of drugs and imaging reagents for therapeutic or ...

COMPARATIVE PHARMACOKINETICS OF PAMAM-OH …

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685189/
    Jun 01, 2013 · COMPARATIVE PHARMACOKINETICS OF PAMAM-OH DENDRIMERS AND HPMA COPOLYMERS IN OVARIAN-TUMOR-BEARING MICE ... Biocompatible water-soluble polymers have been widely used as carriers for a variety of drug-delivery and in vivo imaging applications ... Hashida M. Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations. Pharm ...Author: S. Sadekar, O. Linares, G. J. Noh, D. Hubbard, A. Ray, M. Janát-Amsbury, C. M. Peterson, J. Facelli,...

Dendrimers as Drugs: Discovery and Preclinical and ...

    https://pubs.acs.org/doi/10.1021/mp050023q
    Jun 22, 2005 · Starpharma focuses on the use of dendrimers as drugs in their own right, in contrast to dendrimers as drug delivery vehicles or diagnostics. This contextual review describes how dendrimers offer a unique platform for exploring chemical diversity on the nanoscale and how the production of dendrimer libraries covering a diverse array of macromolecular structures can be used in drug …Author: Tom D. McCarthy, Peter Karellas, Scott A. Henderson, Michael Giannis, David F. O'Keefe, Graham Heery...

Cationic Poly-l-lysine Dendrimers: Pharmacokinetics ...

    https://pubs.acs.org/doi/10.1021/mp060032e
    Cationic poly-l-lysine 3H-dendrimers with either 16 or 32 surface amine groups (BHALys [Lys]4 [3H-Lys]8 [NH2]16 and BHALys [Lys]8 [3H-Lys]16 [NH2]32, generation 3 and 4, respectively) have been synthesized and their pharmacokinetics and biodistribution investigated after intravenous administration to rats. The species in plasma with which radiolabel was associated was also investigated by size ...Author: Benjamin James Boyd, Lisa Michelle Kaminskas, Peter Karellas, Guy Yeoman Krippner, Romina Lessene, C...

Dendrimer-based drug and imaging conjugates: design ...

    https://www.sciencedirect.com/science/article/pii/S1359644610000334
    Potential applications of dendrimers. (a) Dendrimer drug conjugates, dendrimers linked to targeting moieties and imaging agents. (b) Encapsulation of the drugs in the dendritic interiors. (c) Dendrimers incorporated into various delivery systems for enhancing permeation, solubility and so on. (d) Dendrimers as complexing agents.Author: Anupa R. Menjoge, Anupa R. Menjoge, Rangaramanujam M. Kannan, Rangaramanujam M. Kannan, Donald A. To...

Pharmaceutical Research, Volume 28, Issue 7 - Springer

    https://link.springer.com/journal/11095/28/7
    Jul 07, 2011 · Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations. Wassana Wijagkanalan, Shigeru Kawakami, Mitsuru Hashida Pages 1500-1519. Research Paper. Agarose Surface Coating Influences Intracellular Accumulation and Enhances Payload Stability of a Nano-delivery System.

Pharmacokinetic considerations in design of dendrimer ...

    https://www.sciencedirect.com/science/article/pii/B9780128145272000044
    For the development of the delivery system, pharmacokinetic profiling is very much required as it indicates the fate of the delivery system in the body and displays about the potential toxic or beneficial events . 2. Effect of size, molecular weight, hydrophobicity and charge on pharmacokinetic profile of …Author: Lakshmi Tunki, Hitesh Kulhari, Suresh K. Bhargava, Deep Pooja

Searching for Designing Dendrimers For Drug Delivery And Imaging Pharmacokinetic Considerations?

You can just click the links above. The data is collected for you.

Related Delivery Info